HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Releases Final Recordkeeping Rule For Cosmetics With Bovine Material

This article was originally published in The Rose Sheet

Executive Summary

Manufacturers and processors of cosmetic ingredients and finished products that contain cattle material must maintain records that demonstrate their products do not contain prohibited bovine matter, according to an FDA final recordkeeping rule published in a Federal Register 1notice Oct. 11. The rule is effective Jan. 9

You may also be interested in...



Relaxed FDA Rule On Bovine Materials Allows Imports From Non-BSE Nations

An FDA interim final rule easing restrictions on imports of bovine material used in food and cosmetic products is unlikely to significantly affect personal-care firms, according to the industry's trade group

Relaxed FDA Rule On Bovine Materials Allows Imports From Non-BSE Nations

An FDA interim final rule easing restrictions on imports of bovine material used in food and cosmetic products is unlikely to significantly affect personal-care firms, according to the industry's trade group

FDA BSE Rule Permits Tallow With .15% Hexane-Insoluble Impurities

FDA's 1interim final rule prohibiting certain bovine risk materials in cosmetics, dietary supplements and foods to minimize exposure to bovine spongiform encephalopathy will be effective immediately upon publication in the Federal Register, slated for July 14

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014277

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel